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Abstract
Naturally acquired clinical immunity to Plasmodium falciparum is partly mediated by antibod-
ies directed at parasite-derived antigens expressed on the surface of red blood cells which
mediate disease and are extremely diverse. Unlike children, adults recognize a broad range
of variant surface antigens (VSAs) and are protected from severe disease. Though crucial
to the design and feasibility of an effective malaria vaccine, it is not yet known whether
immunity arises through cumulative exposure to each of many antigenic types, cross-reac-
tivity between antigenic types, or some other mechanism. In this study, we measured
plasma antibody responses of 36 children with symptomatic malaria to a diverse panel of 36
recombinant proteins comprising part of the DBLα domain (the ‘DBLα-tag’) of PfEMP1, a
major class of VSAs. We found that although plasma antibody responses were highly spe-
cific to individual antigens, serological profiles of responses across antigens fell into one of
just two distinct types. One type was found almost exclusively in children that succumbed to
severe disease (19 out of 20) while the other occurred in all children with mild disease (16
out of 16). Moreover, children with severe malaria had serological profiles that were nar-
rower in antigen specificity and shorter-lived than those in children with mild malaria. Bor-
rowing a novel technique used in influenza–antigenic cartography—we mapped these
dichotomous serological profiles to amino acid sequence variation within a small sub-region
of the PfEMP1 DBLα domain. By applying our methodology on a larger scale, it should be
possible to identify epitopes responsible for eliciting the protective version of serological pro-
files to PfEMP1 thereby accelerating development of a broadly effective anti-disease
malaria vaccine.
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Author summary
Immunity to human malaria parasites never fully protects against infection, even after a
lifetime of exposure. By contrast, protection against severe disease occurs early in life in
malaria-endemic areas. Both anti-infection and anti-disease immunity depend on anti-
body responses to proteins expressed by the parasite on the red blood cell surface which
cause pathology. These proteins are extremely diverse thus creating a problem for design-
ing a widely effective vaccine. Despite its importance to vaccine design, however, it is not
yet known whether protection against malaria depends on accumulation of exposure to
each of the many antigenic types, or whether this is accelerated due to cross-reactivity
between antigenic types or some other mechanism. In this study, by applying a novel tech-
nique used for describing antigenic diversity in influenza viruses–antigenic cartography—
we make the surprising discoveries that children’s serological responses to a panel of
diverse surface antigens fall into one of just two qualitatively distinct patterns, and that
these almost perfectly predict severity of disease. These alternative serological profiles
were found to associate with genetic variants within in a small region of the protein.
Using the methodology presented here to define the antigenic types and their underlying
genetic variants that give rise to the protective version of the serological response, progress
towards development of a broadly protective vaccine against severe malaria might be
accelerated.
Introduction
The surface of red blood cells (RBCs) infected with Plasmodium falciparum contains antigens
of parasite origin that are highly immunogenic and genetically very diverse [1]. Diversity in
variant surface antigens (VSAs) plays an important role in immune evasion and thus in pro-
longing infections: this affords parasites more opportunities to transmit to new hosts. Acquisi-
tion of antibodies to the most studied family of VSAs–P. falciparum erythrocyte membrane
protein 1 (PfEMP1)—is associated with protection against malarial disease [2,3]. Since
PfEMP1 also plays a key role in pathology due to its property as an adhesion ligand to host
cells [4], this protein family makes an attractive target for vaccine development.
PfEMP1 is encoded by approximately 60 var genes which are genetically diverse within and
between parasite genomes, and which recombine, thus potentially presenting a challenge in
finding a handful of antigens that could form the basis of a broadly effective vaccine. Despite
their genetic diversity, however, var genes structure into distinct groups thus somewhat limit-
ing this pool of variability. These groupings are based on chromosomal position and upstream
sequence (Ups) [5,6]; combinations of domains and sub-domains (domain cassettes, DC)
[5,7–9]; and homology in short sequence blocks found across the full gene (‘homology blocks’,
HB) [7,9] or at positions of limited variability (PoLV) within the DBLα domain [10]. These dif-
ferent classification systems partially overlap [11,12]. Some var genetic groups have been con-
sistently associated with severe disease, denoted here as ‘SM types’, namely, those with Group
A-type upstream promoters (UpsA) [13], domain cassettes 8 and 13 [14], the REY motif at the
PoLV2 position of the DBLα domain [15], and the presence of two cysteines (cys2) between
the PolV3 and PolV4 positions in DBLα [13,16]. PfEMP1 host cell adhesion phenotypes
ICAM-1, EPCR and rosetting have been mapped to expression of specific domains or domain
cassettes thus providing a clear link between PfEMP1 diversity, adhesion phenotype and dis-
ease severity [4].
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Antigenic properties of PfEMP1 are, by contrast, poorly understood. It is known that anti-
bodies against var types associated with severe malaria, such as UpsA and DC8, are readily
detected in young children living in malaria-endemic regions and develop before antibodies to
other types [13,15,17–20]. In addition, VSAs from parasites found in younger children and
those with severe disease are more frequently recognized by sera than those from older or
more immune children: that is, they are more ‘immunologically common’ [2,13,15,21,22].
However, the antigenic properties that differentiate these types are not known. It has been
hypothesised that some var types–those found in younger and sicker children—have immuno-
logical properties that differentially affect the quality and efficacy of the PfEMP1 antibody
response [13]. Possible reasons for stronger antibody recognition of these types are that they
have higher immunogenicity, elevated transcriptional levels, greater protein abundance on the
red cell surface, stronger antigenic conservation, wider cross-reactivity or better ability to
grow inside the host and thus become immunodominant. Some of these hypotheses are sup-
ported by recent studies [13,15,20,23]. Here, we describe the antigenic diversity of PfEMP1 in
relation to severe vs. mild malaria in order to understand this further. To do so, we borrow a
technique used in the study of immune cross-reactivity of influenza A viruses called ‘antigenic
cartography’ [24,25] that is used to annually update flu vaccines in order to cover the ‘antigenic
space’ of the circulating pathogen population [26]. Our overall aim is to lay the foundation for
inferring the subset of antigens that might form a broadly protective PfEMP1-based vaccine.
Results
Serological and DBLα-tag antigen maps
We measured sero-reactivity, both IgG and IgM, of anti-sera from 36 children with severe or
mild malaria to a panel of recombinant proteins that represented part of the DBLα domain
-the DBLα-tag—of dominantly expressed PfEMP1 types found in clinical isolates of 36 chil-
dren (Fig 1, S1 Fig). 32 of the antigens derived from the 36 children that provided antisera. As
expected given the endemicity of malaria in our study site in coastal Kenya, at the time of
recruitment, children in our study had substantial prior history of malaria exposure, evident
from their generally broad recognition and significantly higher sero-reactivity than unexposed
control individuals to recombinant DBLα-tag proteins (Fig 1). Sero-reactivity of IgG with indi-
vidual DBLα-tag proteins was generally higher than sero-reactivity of IgM at acute disease.
This is most likely to be because IgG plasma antibodies reactive with individual DBLα-tags
were generated during previous infections while IgM responses present induction of de novo
responses from naïve B cells and, to a lesser extent, IgM memory B cells. We used analysis of
variance to determine the principal factors affecting sero-reactivity: these revealed that both
antisera and DBLα-tag antigens varied substantially in their average reactivity across antigens/
sera, respectively explaining 39% and 12% of the total variation for IgG, and 13% and 7% for
IgM under analysis Model 1 (Fig 1). These differences were maintained across timepoints (Fig
1, S1, S2 and S3 Figs). In addition, there was strong specificity of reactivity of individual anti-
sera to individual DBLα-tag antigens: this explained a further 24% and 15% of the total varia-
tion in IgG and IgM reactivity, respectively, after excluding data from homologous (i.e.,
derived from the same child) DBLα-tag-antiserum pairs. These patterns of sero-reactivity were
exploited to produce ‘serological maps’ that reflect shared patterns of reactivity of individual
sera with all DBLα-tag antigens, and ‘antigen maps’ that reflect shared patterns of reactivity of
individual DBLα-tags with all anti-sera. Distances between points in these maps correspond to
differences in reactivity patterns between antigens or between sera, respectively.
Serological maps revealed two distinct clusters which we denote serological Clusters I and
II hereon. For IgG, these serological clusters were apparent at the acute stage (Fig 2A) and
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PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1007870 July 1, 2019 3 / 23
remained stable throughout the convalescent period (Fig 2B, S1 & S4 Figs). By contrast, for
IgM, serological clusters were not evident at the acute stage (Fig 2C) but, as convalescence pro-
gressed, despite the overall low sero-reactivity compared to IgG, two clusters emerged which
were the same as those for IgG (Fig 2D, S5 Fig). Serological clusters were still evident after pre-
adjusting sero-reactivity data for mean antisera reactivity (S4 and S5 Figs vs. Fig 2) and thus
were not generated by systematic differences in mean reactivity of sera. Instead, they were
driven by the highly specific nature of serum-DBLα-tag reactivities: this was most obvious for
serological Cluster II antisera which reacted strongly with DBLα-tag antigens P6433, P6408
and P6430 while serological Cluster I sera did not (Fig 1, S1 Fig).
DBLα-tag antigen maps, by contrast, did not show strong clustering at any timepoint for
either IgG or IgM (S6, S7 and S8 Figs). Instead, distances between DBLα-tag antigens were
principally a function of differences in a given DBLα-tag antigen’s mean reactivity (S6 Fig).
Nonetheless, DBLα-tag antigens grouped into five groups (denoted DBLα-tag antigen Clusters
III to VII) using a combination of hierarchical clustering (S7 Fig) and the proportion of anti-
sera strongly recognized (log10 OD > 2) as follows: Antigen Cluster III, ‘high reactivity’ with
>75% anti-sera reactive with these DBLα-tags; Antigen Cluster IV, ‘high specificity’ with 40–
60% of anti-sera strongly reactive and the remaining anti-sera with low reactivity; Antigen
Cluster V, ‘medium specificity and reactivity’ with medium reactivity of anti-sera to a broad
set of DBLα-tag antigens (19–64%) that were largely non-overlapping with the highly reactive
antigens that defined Cluster IV; Antigen Cluster VI with ‘low reactivity’ with<25% of anti-
sera reactive; and Antigen Cluster VII with ‘zero reactivity’ with 0% of anti-sera reactive.
Fig 1. Sero-reactivity patterns of 36 plasma to 36 parasite DBLα-tag recombinant antigens. Square panels show strength of reactivity in log10 OD units (colour bar in
centre) of pairwise combinations of 36 plasma (‘antisera’, columns) and 36 DBLα-tag antigens (rows) at the acute stage of infection for IgG (a) and IgM (b). Colour bars
above and to the left of the heatmaps indicate clinical group (legend at top left). Right side panels show the mean strength of reactivity for the antisera or DBLα-tag antigen
at the acute (A) and convalescent stages of the infection (C1 and C2, see S1 Fig). Corresponding means for plasma from eight Europeans are shown in the colour bar
marked ‘E’: their 95% confidence intervals were below 0.20 log10 OD units for both IgG and IgM. Antisera and antigen labels indicate the patient number from which
parasite material (isolate) and plasma were sourced, prefixed with S and P, respectively. Asterisks mark ‘indicator’ antigens, i.e., antigens that drove the topology of
serological maps.
https://doi.org/10.1371/journal.ppat.1007870.g001
Antigenic cartography in malaria parasites
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1007870 July 1, 2019 4 / 23
Antigen clustering weakened upon pre-adjusting for antigen mean reactivity (S7 and S8 Figs
vs. S1 Fig). Antigenic clusters did not significantly associate with serological clusters (S6 Fig,
P = 0.20 by chi-squared test of association on 4 d.f.).
Fig 2. Antisera maps for IgG and IgM. Maps were constructed from data on a, IgG at the acute timepoint; b, IgG at timepoint C2 (the consensus antisera map); c, IgM
at the acute timepoint; d, IgM at timepoint C2. In b, solid and dashed lines point to positions in the map for IgG at the acute (as in a) and C1 timepoints, respectively. In
b and d, solid lines point to positions in the consensus antisera map shown by the points in b. Symbol size is proportional to the antisera’s average log10 OD value at the
timepoint indicated. R2 values represent goodness-of-fit to the consensus map with subscripts indicating the timepoint of the map being compared and asterisks
indicating significance (���, P< 0.001; ��, P< 0.01).
https://doi.org/10.1371/journal.ppat.1007870.g002
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Serological clusters almost perfectly aligned to clinical group and thus disease severity:
whereas all serological Cluster I sera derived from patients with mild malaria attending the
hospital outpatients department (n = 16), all but one (n = 19) of the Cluster II sera derived
from patients admitted to the hospital wards (Fig 3A, P< 0.001 by chi-squared test on 1 d.f.).
Since host age, parasite density at the time of sampling and average reactivity of the serum did
not differ significantly between clinical groups (Table 1, P> 0.05 by t-tests), the association
between serological clusters and disease is unlikely to have arisen from different levels of prior
exposure in the two clinical groups. There was a significant effect of clinical group on date of
sampling because all six plasma samples collected in 2008 were sourced from patients admitted
to the hospital (Table 1). However, since the association between serological clusters and dis-
ease severity remained highly significant (P < 0.001) after excluding data from the 2008 sam-
ples, this confounding was not responsible for the association, as might be the case, for
example, if the frequency of severe malaria-causing genotypes in the population changed from
year to year.
DBLα-tag antigen clusters did not significantly associate with clinical group (P = 0.36 by
chi-squared test on 4 d.f., Fig 3B). However, all three of the DBLα-tag antigens with very high
specificity, reacting strongly to approximately half the plasma (antigen Cluster IV), derived
from patients with mild disease who had serological Cluster I profiles. DBLα-tag antigen clus-
ter was not significantly associated with other host infection parameters (Table 1).
Effects of heterology of individual antigen-antiserum pairs
At the acute stage of infection, IgG sero-reactivity of homologous antigen-antiserum pairs (i.e.,
both the plasma and parasite isolate from which the dominant DBLα-tag was cloned were
sourced from the same child) was significantly lower than for heterologous antigen-antiserum
pairs (P< 0.001 under Model 2, Fig 4A vs. 4B and 4C). This effect disappeared in the conva-
lescent phase during which antibodies to homologous DBLα-tags significantly increased
(P< 0.001 fitting timepoint as a linear covariate) while those to heterologous DBLα-tags sig-
nificantly declined (see below). These findings are consistent with those from previous studies
showing that children are more likely to become infected with PfEMP1 antigenic types not
encountered previously, and that they subsequently mount antibody responses that are pri-
marily specific to the infecting antigenic type [2,27–29].
Serological clusters differ in their quality of immune response
There were no differences between serological Cluster I and II in the homologous IgG response
(P> 0.05 at all timepoints under Model 4, Fig 4A). By contrast, Cluster I and II antisera
responded differently to heterologous DBLα-tag antigens. Acute stage plasma belonging to
serological Cluster I had lower IgG reactivity to heterologous DBLα-tag antigens from children
with the same serological cluster than to antigens from the opposite cluster (Fig 4B vs. 4c,
P< 0.01 and P< 0.05 at the A and C2 timepoints under Model 3), similar to the heterology
effect for individual antigen-antisera pairs. By contrast, serological Cluster II had similar or
higher IgG sero-reactivity to DBLα-tags from children with the same serological cluster than to
antigens from the opposite cluster (P = 0.04 for timepoint C3 and P> 0.05 at the A and C2
timepoints under Model 3, Fig 4B vs. 4C). Serological Cluster II profiles further differed from
serological Cluster I profiles in that–with the exception of responses to homologous antigens—
antisera levels declined significantly during convalescence (Fig 4B and 4C, P< 0.001 for Cluster
II vs. P> 0.05 for Cluster I fitting timepoint as a linear covariate in Model 3). Serological cluster
and cluster heterology effects for IgM patterns were qualitatively similar, though weaker, to
those for IgG (Fig 4D, 4E and 4F).
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Combined, these results suggest that children develop one of just two qualitatively distinct
serological profiles with respect to the DBLα-tag antigen which align with disease outcome of
the infection. Serological Cluster I profiles appear to be broadly reactive, long-lasting and,
while less effective in protecting against infection with non-SM than SM types, nonetheless are
effective in preventing progression to severe disease. Serological Cluster II profiles, by contrast,
while generally stronger at the time of acute infection, appear to be narrowly specific, transient,
non-protective against infection with all types—both SM and non-SM—and ineffective in pre-
venting progression to severe disease.
Genetic diversity in DBLα-tag antigens and correspondence with
serological and antigenic diversity
Genetic maps based on the full amino acid sequence of the DBLα-tag region of PfEMP1, like
serological maps, revealed two genetic clusters (denoted Genetic Clusters VIII and IX) (Fig 5).
These corresponded to the 2-cysteine vs. not-2-cysteine major genetic groupings described
previously [10] (Fig 5B, P< 0.001 by chi-squared test). Genetic cluster and PoLV group did
not significantly associate with clinical group (Fig 3C, P = 1.00 and P = 0.20, respectively),
serological cluster (P = 1.00 and P = 0.13, respectively), or DBLα-tag antigen cluster (P = 0.91
and P = 0.35, respectively) or any of the host and infection variables described above (Table 1).
Fig 3. Associations between disease severity and clusters. Frequency distributions of clinical group (x-axis, disease
severity) by a, serological cluster; b, antigen cluster; c, genetic cluster; d, PoLV group. Significance (P-values) for chi-
squared tests of associations between clinical group and clusters are shown at the top of each panel.
https://doi.org/10.1371/journal.ppat.1007870.g003
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Sliding window analysis of genetic maps based on 14 amino acid sub-regions in relation to
serological, DBLα-tag antigenic and genetic clusters indicated that serological clustering was
principally driven by genetic diversity between Segments 2 and 3 at the N-terminal portion of
the DBLα-tag ending with PoLV2 (Fig 6A and S9 Fig). This region comprises almost complete
S2b and S2c sub-domains of DBLα domains as defined by Rask et al. (2010) [9]. High concor-
dance between serological clustering and genetic diversity in this region was driven by the fact
that all but one (P6408) of the nine antigens that contained a REY motif at the PoLV2 position
Table 1. Associations between clinical parameters, serological responses, parasite genetic factors and clusters found in serological and genetic diversity maps.
Clinical group median (range) P-valueb
ups group &
DCa
Mild disease
(n = 16)
Severe disease
(n = 20)
Clinical
group
Serological
cluster
Antigen cluster Genetic
cluster
Host and infection parameters
Parasite density (p/μl) 170,000
(13,440–
680,000)
201,600
(18,414–1,680,000)
0.2403 0.1239 0.2442 0.8996
Age (mo) 45 (9–83) 40 (4–73) 0.2928 0.9841 0.7870 0.6981
Date Jun 2006
(Jul 2005–Jan
2007)
Jan 2007
(Jul 2005 –Jul 2008)
0.0002 0.0003 0.3310 0.7929
Mean IgG antisera reactivityc 1.82 (1.52–2.23) 1.93 (1.05–2.40) 0.8693 0.9551 0.2579 0.4592
Mean IgG antigen reactivityd 1.77 (0.60–2.83) 1.81 (0.66–3.34) 0.5894 0.2708 <0.0001 0.6522
Mean IgM antisera reactivity 0.90 (0.63–1.14) 0.91 (0.43–1.60) 0.9333 0.9923 0.1647 0.1154
Mean IgM antigen reactivity 0.83 (0.29–1.75) 0.96 (0.29–1.84) 0.3011 0.0187 (I<II)e 0.0019 0.4959
Parasite genetic factors
Global frequencyf 0 (0–31) 1 (0–50+) 0.3107 0.4279 0.9894 0.1511
Homology Block 1g 29.8 (10.5–34.5) 22.9 (0–33.1) 0.0031 0.0005 0.5012 0.4995
Homology Block 54 0 (0–18.6) 11.7 (0–20.5) 0.0717 0.0716 0.3087 0.0705
Homology Block 64 6.3 (0–18.2) 0 (0–16.9) 0.0443 0.0883 0.6857 0.0496
Homology Block 36 35.0 (0–58.1) 37.2 (0–50.4) 0.7212 0.8615 0.3659 <0.0001
Homology Block 60 5.1 (0–38.6) 0 (0–46.6) 0.8475 0.8853 0.3303 <0.0001
DBLa_CIDRah B (DC8) 0.2 (0–11.1) 2.7 (0–46.6) 0.0430 0.1269 0.3583 0.4571
DBLg4/6 B (DC8) 0.1 (0–19.0) 7.4 (0–33.7) 0.0064 0.0116 0.4568 0.6836
CIDRa1.1 B (DC8) 0.1 (0–661) 11.6 (0.1–115) 0.0073 0.0246 0.4143 0.9236
DBLb12 and DBLb3/5 A/B (DC8) 0.4 (0–64.7) 12.7 (0.1–79.0) 0.0058 0.0264 0.2935 0.4642
DBLz4 B (DC9) 1.7 (0–14.9) 4.2 (0–82.7) 0.8533 0.7234 0.4496 0.3562
CIDRa1.4 A (DC13) 0.0 (0–2.9) 0.3 (0–50.7) 0.0025 0.0098 0.6315 0.8664
DBLa2/a1.1/2/4/7 A 3.0 (0.3–101) 41.7 (2.5–134) 0.0109 0.0357 0.2866 0.3085
CIDRa1.6 A 0.0 (0–17.2) 0.1 (0–48.3) 0.3678 0.5028 0.6319 0.0629
DBLa1 not var3 A 3.4 (0.1–128) 40.8 (0.8–258) 0.0058 0.0163 0.1801 0.2449
b1 B 2.0 (0–29.5) 10.2 (0.8–157) 0.0590 0.0475 0.5151 0.9812
c2 C 0.7 (0–2.8) 2.7 (0.1–19.8) 0.0045 0.0121 0.6856 0.3666
a. Classification based on upstream promoter (ups) and domain cassette (DC, in parentheses).
b. P-values (P < 0.05 in bold) for t-tests of the effects of clinical group, serological cluster, antigen and genetic cluster (columns, assessed under Models 7, 3, 5 and 6,
respectively) on host and infection factors (rows, top section) and for Wilcoxon rank tests for parasite genetic factors (lower section).
c. Mean OD for antibodies belonging to the group indicated in the table column.
d. Mean OD for antigens belonging to the group indicated in the table column.
e. The mean for serological Cluster I was lower than for Cluster II.
f. Number of isolates in the var gene database [30] with >95% DNA sequence identity to the full DBLα-tag. ‘50+’ denotes >50.
g. Homology block as defined in ref. [9]. Values are scores from BLAST analyses in the var gene domain database [31].
h. Primer name for measuring transcript levels as defined in ref. [14].
https://doi.org/10.1371/journal.ppat.1007870.t001
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(PoLV Groups 2 and 5) derived from patients with serological Cluster II profiles, while only
one REY type was found in patients with serological Cluster I profiles (Fig 7, S9B and S9E Fig).
Previous evidence suggests that parasites expressing PoLV/Cys Group 2 [10] and Group 5 [32]
are likely to form rosettes, a cytoadhesion phenotype strongly implicated in severe disease [33–
35]. This, together with our findings, suggests that epitopes in the S2b sub-domain of DBLα
REY sequence type, or elsewhere in the PfEMP1 protein but in strong linkage disequilibrium
with the latter, are the target of antibodies that are associated with a milder course of disease.
Genetic clustering was strongly associated with sequence diversity in Segments 4 and 5 at
the 3’ end of the S2c sub-domain of DBLα, consistent with location of the cysteines that distin-
guish two major genetic groups under the PoLV/Cys classification system [10] (Fig 6B).
We explored other genetic aspects of the DBLα domain for their relationship with disease
and serological clusters. Recognition scores for homology blocks HB14 and HB64 were
Fig 4. Effects of heterology. Each panel shows least-squares means (circles) with 95% confidence intervals (vertical
bars) of IgG (a, b, c) and IgM (d, e, f) sero-reactivity for DBLα-tag antigen-antisera pairs split by timepoint and
serological cluster (Antisera I and II on x-axis). In a and d, data are from antigen-antisera pairs that derive from the
same host, (i.e., are homologous). In b and e, data are from antigen-antisera pairs that are heterologous with respect to
individual antigens/antisera but which derive from hosts in the same serological cluster. In c and f, antigen-antisera
pairs are heterologous with respect to both individual antigens/antisera and serological cluster. Colour of outer circles
and lower horizontal bars below the x-axis indicate serological cluster; colour of inner circles and upper horizonal bars
indicates serological cluster of the host from which the DBLα-tag antigen derived. Black inner circles and upper black
horizontal bars indicate homologous antigen-antisera combinations. P-values of statistical tests for the effect of
serological cluster at each timepoint are shown in black text with horizontal brackets. n.s., P> 0.05; ���, P< 0.001.
https://doi.org/10.1371/journal.ppat.1007870.g004
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significantly elevated in DBLα-tags derived from parasites from patients with mild disease and
serological Cluster I profiles, while those of HB54 were elevated in in DBLα-tags derived from
parasites from patients with severe disease and serological Cluster II profiles (Table 1). These
three homology blocks span Segments 1, 2 and 3 of the DBLα domain (Fig 7), thus corroborat-
ing the strong association between serological cluster and genetic diversity in the S2b sub-
domain described above.
Recognition scores of HB60 and HB36 were significantly positively associated with Genetic
Clusters VIII and IX, respectively (Table 1), consistent with their location in Segments 4 and 5
in which variation in the number of cysteines that delineate these clusters occurs (Fig 7).
Genetic features outside the DBLα-tag
The analysis above focused on sero-reactivity of plasma to the DBLα-tagα of the dominant
expressed PfEMP1 in clinical isolates. We next addressed whether underlying genetic charac-
teristics of the full length PfEMP1 protein in the entire parasite population of a given child,
such as expression of specific domain cassettes or upstream promoter sequences were associ-
ated with serological or antigenic clusters. We found that expression levels of domain cassettes
DC8 and DC13 were significantly positively associated with severe disease and serological
Cluster II or both (Table 1), consistent with previous studies [14,20]. Expression levels for
three out of four other markers of var subtypes associated with severe disease in previous stud-
ies were significantly associated with disease in this study (Table 1): two of these markers
define DBLα sub-types that belong to the upstream promoter Group A (DBLa2/a1.1/2/4/7 and
DBLa1). Surprisingly, a generic group C marker that has been previously associated with mild
disease was also elevated in children admitted to hospital: however, expression levels of Group
C upstream promoter regions were low in all groups (Table 1).
Fig 5. Genetic maps. a, Genetic map (points) with reference (lines) to the consensus antisera map (IgG at C2). Goodness-of-fit was not significant (R2 = 0.07,
P = 0.25). b, Genetic map coloured by PoLV groups. Point size is as for the consensus antisera map (see Fig 2).
https://doi.org/10.1371/journal.ppat.1007870.g005
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Global population frequency of the parasite’s var genes, as judged by number of highly sim-
ilar sequences to the full DBLα–tag in the global var gene sequence database, did not associate
with disease severity or clusters (Table 1). Thus, the association between disease severity and
antigenic profile was not explained by the rarity of, and hence degree of prior exposure to the
var gene products of the infecting isolate.
Overall, our genetic analysis of the parasites in this study confirms the conclusion from pre-
vious studies that a subset of genetically defined PfEMP1 types–those with DC8, two cysteines,
and Group 2 and Group 5 REY types—are strongly predictive of severe disease. By introducing
serology into analysis of this relationship, we have shown that protection against these SM
types may depend on serological responses to epitopes in the S2b sub-domain of DBLα, or epi-
topes elsewhere in the PfEMP1 protein that are in strong linkage disequilibrium with these. By
contrast, protection was not associated with putative epitopes in the S2c sub-domain which
delineates the two major genetic groups by its number of cysteines, Cys2 and non-Cys2.
Discussion
This study has revealed that, despite different histories of malaria and diversity of antigenic
types, serological responses to PfEMP1 in children fall into one of just two qualitatively
Fig 6. Sliding window analysis for regions of sequence that predict antigenic and genetic clusters. Correspondence
(y-axis, measured by R2) between genetic sub-maps built from sequence similarity in 14-residue windows (x-axis,
midpoint of window) and a, serological clusters; and b, genetic clusters. Positions (window midpoints) that best define
serological and genetic clusters, respectively, are shown with vertical arrows. Horizontal dashed lines in a and b
indicate the P = 0.05 significance level for R2 from permutation tests. PoLV1 and PoLV2 positions are indicated by
grey boxes. The consensus sequence is shown at the top of panel a.
https://doi.org/10.1371/journal.ppat.1007870.g006
Antigenic cartography in malaria parasites
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1007870 July 1, 2019 11 / 23
different patterns which strongly associate with disease severity. In most children, serological
responses to PfEMP1 (here evaluated using recombinant DBLα-tags representing the domi-
nantly expressed PfEMP1) are broadly reactive and long-lasting, but in some children–those
that succumb to severe disease—responses are narrower and short-lived. This conclusion,
Fig 7. Amino acid sequence alignment of the DBLα-tag recombinant proteins. Coloured residues indicate identity with the consensus sequence which is shown at the
top; grey residues indicate differences from the consensus. Dashes indicate non-presence of the consensus residue. The sequence divides into six segments of moderate
homology (black text below figure) and into two sub-domains, S2b and S2c as defined in ref. [9] (black horizontal lines at top). Positions (window midpoints) that best
define serological and genetic clusters, respectively, are shown with vertical arrows, corresponding to those shown in Fig 6A and 6B, respectively. Parasite isolates, their
clinical group, cluster membership and PoLV groups are indicated in black text to the left of the figure. Coloured blocks at the top of the figure show homology blocks
(HB) as defined by Rask et al. (2010). The most highly conserved HBs across the global population are shown at the top: below these are less conserved HBs that showed
significant associations with disease severity, serological cluster (HB14, HB54 and HB64) and genetic cluster (HB36 and HB60) in this study (Table 1).
https://doi.org/10.1371/journal.ppat.1007870.g007
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based on the similarity of serological profiles between children to a set of related antigens
rather than on the frequency of responses to individual antigens–as in most immuno-epidemi-
ological studies—departs from the traditional view that protection against malarial disease is
acquired in a piecemeal fashion through acquisition of specific antibodies to each of PfEMP1’s
many antigenic types upon repeated exposure [36,37]. It shifts the focus in understanding
severe malaria away from individual antigenic types towards the overall quality of the antibody
response.
As in many previous studies [13,15,17–20], we observed that PfEMP1 (here represented by
DBLα-tags) from parasites that caused infections which progressed to severe disease were gen-
erally better recognized by plasma than those from infections resulting in mild disease (Figs 1
and 4). How does this reconcile with our proposal that patients with severe disease mount
serological responses that are less effective and less persistent? Although var genes are very het-
erogenous in sequence within and between genomes, they share sequence similarities that
define domains, homology blocks and binding-sites for endothelial receptors, as also reflected
in short shared stretches of sequence similarities within the DBLα-tag region [38]. These sites
could be targets of cross-reactive serological responses. Cross-reactive antibody responses can
be short-lived when the corresponding antibodies originate from memory B cells that differen-
tiate into short-lived plasma cells, or long-lived when antibodies originate from long-lived
plasma cells. Our data suggest that children with mild disease maintain stable antibody
responses to heterologous DBLα-tag antigens, with levels generally higher to DBLα-tag anti-
gens derived from parasites of children with severe malaria, while children with severe disease
have similar levels of serological responses to heterologous DBLα-tag antigens of all parasite
types which drop significantly during convalescence. Given that memory B cells tend to leave
germinal centres earlier than long-lived plasma cells during affinity maturation [39], it seems
likely that the short-lived serological Cluster II IgG responses originated from short-lived
plasma cells that had lower affinity for heterologous DBLα-tags, and that these qualitative dif-
ferences contributed to the association of serological profiles with disease severity that we
observed here.
Remarkably, serological profiles for IgM and IgG were similar at the convalescent stage.
IgM memory B cells contribute—and sometimes are the earliest responders [40]–to the rapid
boosting of antibody levels during re-infection. However, differentiation of naïve B cells in
response to new antigenic variants increases levels of plasma IgM memory B cells too.
Although the source of plasma antibodies to the different DBLα-tag antigens has to be further
investigated, we thus hypothesise that the different sources and quality of memory B cells may
underlie the reason for why children that have developed Cluster I serological profiles in
response to previous infections are protected from severe disease, even when they become
infected with SM types, while children with Cluster II profiles are not. We further note that the
decoupling of the roles of antigen and serological responses in severe disease under this
hypothesis contrasts with that for establishment of an infection which clearly depends on
highly specific reactivity to individual antigenic types.
Although severe disease is clearly linked with PfEMP1 type, such as expression of DC13,
DC8 or group A PfEMP1 associated with rosetting, expression of these SM-PfEMP1 types is
not sufficient for the development of severe disease since they are also expressed during first
infections, whether or not the child develops severe malaria, and because children readily
induce antibodies against SM-PfEMP1 [14]. Our data suggests that this gap is filled by some
qualitative feature of the host’s immune response that causes failure to develop an adequate
anti-SM-PfEMP1 response. Possible reasons for this include host-derived factors that influ-
ence the general quality of the immune response such as haemoglobinopathies which alter dis-
play of PfEMP1 on the red cell surface [41]; parasite-induced epigenetic modification of
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immune cell function [42]; PfEMP1-mediated inflammation resulting in dysregulation of T-
and B cell function [43] or antibody-dependent cellular cytotoxic function [44]; and RIFIN-
mediated binding to LILRB1 expressed on B cells [45]. Clearly, underlying host genetic factors
and cellular events that result in distinct serological profiles between children with mild vs.
severe malaria disease require further investigation.
Alternatively, the failure may be directly attributable to the parasite. Theoretical modelling
of within-host infection dynamics has led to the hypothesis that in order to produce sequential
expression of individual var genes during the course of an infection, the parasite must induce
the immune system to produce long-lasting, cross-reactive antibodies as well as transient,
highly specific antibodies to the current numerically dominant variant [46]. Empirical studies
have shown that, in patients with severe disease, var gene expression is dysregulated, leading to
the appearance of multiple var types simultaneously instead of sequentially: this has been
linked to down-regulation of parasite histone deacetylase PfSIR2A, an epigenetic silencer of
var gene expression [20,47]. The latter two observations, together with our results here, sup-
port a model in which hosts mount one of two types of immune response to PfEMP1 –one
(Cluster I-like) in which var gene expression is well-regulated, this with assistance from long-
lasting antibody seroreactivity, and which culminates in control of severe disease; and the
other (Cluster II-like) in which many vars are expressed simultaneously, generating an anti-
body repertoire that is broader but less effective, presumably as a consequence of generating
fewer antibodies to each type and which thus gives the appearance of transience.
Such a model must include an antigen-antiserum specific component, however, since our
conclusion that protected children mount broader and longer serological responses than
unprotected children does not sufficiently explain the serological reactivity patterns in our
data. We found that it was not the overall quantity of plasma antibody, but instead the highly
specific nature of the immune profiles which delineated serological Cluster I from Cluster II
and mild from severe disease patients. The serological specificity that drove these differences
was particularly obvious among a small subset of DBLα-tag antigens (P6433, P6408 and
P6430, Fig 1, S7 Fig). Perhaps surprisingly, these ‘indicator’ antigens were only recognized by
children with severe disease and all of them derived from children with mild disease (S1 Fig).
We therefore interpret strong responses to this subset of antigens in children with severe
malaria as an indication of, rather than the cause of, a defective immune response.
A variant-specific basis for the relationship between serological antibody profile and disease
outcome is further supported by the results of our analysis relating distinct serological profiles
to genetic variation within PfEMP1. We mapped diversity in serological responses to genetic
diversity in HB14, a short region of semi-conserved sequence in the S2b sub-domain of
PfEMP1’s DBLα domain. HB14 spans a hypervariable loop (Fig 6 & S9 Fig) between two alpha
helices that form the core structure of this sub-domain: these are marked by conserved
sequences HB3 at the 5’ end and HB5 at the 3’ end. HB5 is believed to be frequently exposed
on the surface of PfEMP1 [9]: the adjacent hypervariable region marked by HB14 may also be
frequently exposed to the host’s immune system. Just downstream from HB14 and marking
the beginning of HB5 is a short motif–REY or RED. REY defines genetic sub-groups (PoLV
Groups 2 and 5) which have previously been reported to be associated with severe malaria,
particularly rosetting [32]. REY-type HB5 tend to have shorter segments in the HB14 region
(Fig 7). Sero-reactivities against REY-containing DBLα-tag sequences are acquired early in life
in children living in Papua New Guinea [48]. Taken together, these findings suggest that the
length and/or diversity of the hypervariable loop exposed on the surface of PfEMP1, as defined
by HB14, might provoke antibody responses that qualitatively differ in their efficacy in con-
trolling progression to severe disease.
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Since we did not sequence the full length of the var genes, we could not determine the com-
plete set of genetic variants that best predict serological profile and how these relate to Group
A, DC8 and DC13 var types that generate severe malaria. Given the genetic structure of var
genes, it is likely that HB14 and HB5 in the DBLα domain are in linkage disequilibrium with
cassette types in other domains. A much larger study is required to identify all the potential
epitope sites in PfEMP1 that could explain the dichotomous serological profiles that we have
revealed here. Such a study would constitute a significant step towards the development of a
broadly effective PfEMP1-based malaria vaccine. Unlike vaccines for other highly genetically
diverse pathogens such as influenza A, in which antigen components are selected to cover the
full antigenic diversity of the currently circulating population, and which require updating for
each global hemisphere every year [25,26], the challenge will be to define PfEMP1 types that
elicit the long-lasting, protective version of the antibody repertoire, as found in most children
in malaria-endemic areas, and which we have begun to define here.
Materials and methods
Ethics statement
Children were recruited into this study after written informed consent from their parents or
guardians. Ethical permission for the study was granted by the National Ethical Review Com-
mittees of Kenya (Kenya Medical Research Institute protocol SSC1131) and the Oxford Tropi-
cal Research Ethics Committee (OXTREC protocol no. 30–06).
Study population
Thirty-six children under the age of 5 years presenting with acute malaria at the Kilifi County
Hospital, Kilifi, Kenya each donated a venous blood sample at recruitment (Acute, A), at 4
weeks (Convalescence 1, C1) and at 16 weeks (C2) after the acute malaria episode. Children
were either admitted to the hospital ward according to pre-established criteria for severe
malaria (Blantyre coma score <5, Hb<5g/dl or respiratory distress [49]) or moderate malaria
(admitted to the ward but without any of these severe malaria syndromes): otherwise they
were diagnosed as ‘mild malaria’, treated with anti-malarial drugs at the Outpatient Depart-
ment (OPD) and sent home. Plasma and parasite material were collected upon recruitment
and separated and stored using standard procedures [50].
Antigen preparation
The dominant expressed var gene in each isolate at the time of recruitment was identified
based on the DBLα-tag as described previously [50,51]. For 36 of the isolates for which a domi-
nant var transcript was able to be identified, DBLα tags were cloned and expressed in BL21
(DE3) pLysS E.coli cells to give recombinant proteins (‘antigens’) as previously described [50]
(S1 Table).
Sero-reactivity to recombinant proteins
Each antigen was screened for sero-reactivity to each of 36 plasma (‘antisera’) collected at each of
the three timepoints (A, C1 and C2). Thirty-two of these plasma samples came from the same
children from which the 36 recombinant proteins derived. Sero-reactivity was measured by coat-
ing 96-well NuncTM MaxisorbTM immunoplates plates overnight at 4˚C with recombinant pro-
tein diluted in Tris-buffered saline (TBS) at a concentration of 1μg/ml. Plates were blocked with
3% bovine serum albumin (BSA) in TBS, washed and then incubated in duplicate at a 1:200 dilu-
tion of individual sera diluted in 1% non-fat milk powder in TBS. After incubation for 2h at
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room temperature, plates were washed, then bound antibody was detected with mouse anti-
human IgG alkaline phosphatase antibody or AffiniPure donkey anti-human IgM alkaline phos-
phatase antibody (Jackson ImmunoResearch Laboratories, Inc.) diluted 1:5000 in 1% non-fat
milk powder in TBS. The reaction was developed using o-Phenylenediamine dihydrochloride
(Sigma-Aldrich) and then stopped with 2M sulphuric acid. Optical density (OD) was read at
450nm in an ELISA microplate reader (BioTek Synergy 4, BioTek Instruments).
Statistical analysis
Prior to building antigen and serological maps, sero-reactivity levels (log10 OD values) were
explored for systematic effects of timepoint, DBLα-tag antigen and antisera by conducting
analysis of variance fitting a series of mixed linear models in the lme4 package in R [52]. Model
1 included a fixed effect for timepoint (sometimes fitted as a fixed-level factor and sometimes
as a continuous variable) and random effects for antigen and antisera within antigen: the latter
term thus tested for interactions between antigens and antisera. Model 2 was as for Model 1
but substituting antisera within antigen with a fixed effect for ‘heterology’, i.e., whether the
antigen-antisera pair was from the same patient (homologous) or not (heterologous). Model 3,
which was only applied to data from heterologous antigen-antisera pairs, fitted fixed effects for
timepoint, serological cluster of the antisera (see below), and serological cluster of the antigen,
with all possible interactions between these, and random effects for antigen and antisera.
Model 4, which was only applied to data from homologous antigen-antisera pairs, fitted fixed
effects for timepoint, serological cluster of the antisera, the interaction between these and a
random effect for antisera. Model 5 fitted fixed effects for timepoint and antigen cluster (see
below) and random effects for antigen and antisera. Models 6 and 7 were as for Model 5 but
fitting genetic cluster (see below) or clinical group instead of antigen cluster. Means for fixed
effects after adjusting for other fixed and random effects (least-squares means) were computed
using the lsmeans package in R [53]. Pairwise contrasts between fixed effects of interest were
formed using the same package with no adjustment for multiple testing. The variation due to
antigen, antisera and their interaction was described by the ratio of the corresponding variance
estimate (from the random effect) to the total variance remaining after accounting for fixed
effects. Significance levels of all fixed and random effects were determined by likelihood ratios
from models with and without the term of interest included. Estimates presented are from
models in which interaction terms with P> 0.05 were removed.
Associations between categorical variables (disease severity class (‘clinical group’), antigen clus-
ter, serological cluster and genetic cluster, as defined by maps (see below)) and normally distrib-
uted host and infection-related variables (parasite density, age, date of collection at the time of
recruitment) were tested for significance using F-tests in a fixed effect analysis of variance with the
latter as the dependent variables. Associations between categorical variables and non-normally
distributed traits (DNA sequence global population frequency, homology block scores, relative
gene expression levels for domain cassettes, see section below on genetic characteristics) were
tested for significance using a two-sided Wilcoxon rank sum non-parametric test implemented by
the ‘wilcox.test’ function in the R stats package [54]. Tests for relationships between clusters and
categorical variables were performed using chi-squared tests of association using the ‘chisq.test’
function in the R stats package with Monte Carlo simulation for computation of P-values [54].
Antigen and antisera maps
Antisera ‘maps’ (a representation of pairwise antisera ‘distances’, with respect to the antigens
they ‘read’ antigens) were generated from the 36 x 36 matrix of sero-reactivity data using mul-
tidimensional scaling (MDS) implemented by the ‘cmdscale’ function in the stats package of R
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[54]. The elements of the distance matrix used as input for MDS were computed as (dij/dmax)2
where dij is the Euclidean distance between the vector of sero-reactivities of antisera pairs i and
j and dmax is the maximum Euclidean distance for all pairs, calculated using the ‘adjacency’
function in the WGCNA package in R [55]. Maps were fitted in two dimensions and con-
structed from data with and without adjusting for mean differences in sero-reactivity across
antigens of each antisera. Two further aids to visualization of antisera diversity were used.
First, heatmaps of the distance matrix were created using the pheatmap package in R [56] and
plotted with dendrograms based on hierarchical clustering (‘hclust’ function using the ‘aver-
age’ method in the R stats package [54]. Second, networks were constructed from the lowest
20% of distances in the distance matrix using the Davidson-Harel algorithm in the igraph
package in R [57]. Antigen maps were similarly constructed but based on distances between
pairs of antigens instead of antisera.
Note that the application of ‘antigenic cartography’ here differs from its original use [24,25]
in that the plasma were polyclonal rather than monoclonal due to prior history of malaria in
study children and the fact that multiple PfEMP1 types are expressed within the lifetime of a
single infection. We did not attempt to adjust for previously existing levels of antibodies since
our main interest was to relate existing antisera profiles at the time of infection, rather than
responses to the current infection, to disease severity.
Genetic maps were constructed by MDS of the distance matrix based on amino acid
sequence similarities after alignment using the clustalw algorithm implemented in the Gen-
eious software [58] with gap open and extension penalties of 12 and 3, respectively. The genetic
distance matrix was calculated using the ‘seqidentity’ function in the bio3d package in R [59].
Antigenic, serological and genetic clusters were defined by a combination of visual inspec-
tion of MDS maps and hierarchical clustering of the distance matrices.
Genetic characteristics–PoLV/Cys classification, homology blocks, cassette
domains, upstream promoter type and population frequencies
Antigens were categorized based on their amino acid sequence into six ‘PoLV/Cys2’ groups
(Groups 1 to 6) based on motifs at four ‘positions of limited variability’ (PoLV) within the DBLα
domain and by number of cysteine residues (Cys) - 2 vs. not-2—in the region between the third
and fourth PoLV (PolV3 and PolV4) as described previously [10,51]. The two major groups
defined by number of cysteines (Groups 1–3 vs. Groups 4–6) further divide into those containing
a REY vs. non-REY motif at the second PoLV (PoLV2) (Groups 2 and 5 vs. Groups 1, 3, 4 and 6).
REY types are shorter than non-REY types and are further distinct in their sequence between
PoLV1 and PoLV2 [10]. Antigens were also classified for the presence of predicted ‘homology
blocks’ by analyzing the DBLα-tag sequences on the “varDom” server [9,31]. The presence of spe-
cific domain cassettes, particularly (DC) 8 and 13—combinations of protein sequences from the
DBLα, DBLα, DBLα and CIDR domains of PfEMP1 that have been previously strongly associ-
ated with severe malaria [14,20]–were determined using real-time quantitative PCR for each par-
asite isolate as described previously [14]. Upstream promoter type (A, B or C) of the antigens was
likewise determined by real-time PCR [9,14]. Nucleotide sequences of each DBLα-tag was blasted
against the DNA sequence in the global var gene database [30]. The number of var genes in the
database which contained DBLα-tag nucleotide stretches with 95% or more identity to each
DBLα-tag sequence was counted to estimate the ‘global population frequency’ of the sequence.
Mapping of antigen and serological diversity to genetic sub-regions
To determine whether some sub-regions of the DBLα-tag sequence might better explain anti-
genic or antisera diversity than others, a sliding window analysis was performed in which a
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genetic sub-map built from sequence similarity based on windows of 14 amino acids, each off-
set by one, was assessed for concordance with the consensus antigenic or antisera map. Con-
cordance was statistically evaluated by fitting a linear model to the distance matrix of the
genetic sub-map with antigen or serological cluster as a fixed effect using the ‘adonis’ multivar-
iate analysis of variance function in the vegan package in R [60]. 1200 permutations of the data
were performed to determine significance levels. Concordance between genetic and antigenic
or antisera maps was also assessed by computing the sum of squared differences (SS) between
point locations in the two maps after rotating and scale transforming the antigenic or antisera
map such that it minimized the SS, as implemented by the ‘procrustes’ function in the vegan
package in R [60]. The P-value for observed goodness-of-fit statistic, R2 (= 1-SS), was com-
pared to that of its empirical distribution generated from 1200 random permutations of the
antigenic or antisera map using the ‘protest’ function in the vegan package This second statisti-
cal test was applied to maps built both across and within antigenic or antisera clusters.
Supporting information
S1 Table. Accession numbers for antigens.
(DOCX)
S1 Fig. Heatmaps of DBLα-tag antigen by antisera reactivity patterns for IgG and IgM by
timepoint. Heatmap colours show strength of sero-reactivity between DBLα-tag antigens
(rows) and antisera (columns) (red, high reactivity; blue, low reactivity) at the acute (a, b), C1
(c, d) and C2 (e, f) time points for IgG (a, c, e) and IgM (b, d, f). Colours in side bars indicate
clinical group, serological cluster, antigen cluster, genetic cluster, PolV group (legends in cen-
tre) and individual antigen/antisera. Row and column orders for all panels are the same as in
(a) and in Fig 1 of the main text. Asterisks mark ‘indicator antigens’ (see main text). Data are
not pre-adjusted for mean antisera and mean antigen levels.
(TIF)
S2 Fig. Mean reactivity of DBLα-tag antigens by timepoint. Mean reactivity (measured in
log10 OD units) across 36 antisera for each of 36 DBLα-tag antigens (circular symbols, one col-
our per antigen, as in S1 Fig) at the time of acute disease (x-axis) vs. that at the first (C1) and
second convalescent (C2) timepoints (y-axes) for IgG (panels a and b) and IgM (panels c and
d) (y-axes). The dashed horizontal line shows the 95% confidence limit for reactivity of the 36
antigens to 8 sera from Europeans with no history of infection with P. falciparum.
(TIF)
S3 Fig. Mean reactivity of antisera by timepoint. Mean reactivity (measured in log10 OD
units) across 36 DBLα-tag antigens for each of 36 antisera (circular symbols, one colour per
serum) at the time of acute disease (x-axis) vs. that at the first (C1) and second convalescent
(C2) timepoints (y-axes) for IgG (panels a and b) and IgM (panels c and d) (y-axes). Antisera
showing abnormally low responses at a single timepoint are labelled in black text. The dashed
horizontal line shows the 95% confidence limit for reactivity of the 36 antigens to 8 sera from
Europeans with no history of infection with P. falciparum.
(TIF)
S4 Fig. Heatmaps and network representations of antisera similarity based on IgG
responses. Heatmap colours show degree of similarity between antisera (red, most similar;
blue, most distant) based on IgG responses at the acute (a), C1 (c) and C2 (e) stages. Colours
in side bars indicate clinical group, serological cluster, antigen cluster, genetic cluster, PoLV
group (legends in centre) and individual antisera. Asterisks mark antisera derived from the
Antigenic cartography in malaria parasites
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1007870 July 1, 2019 18 / 23
same host as indicator antigens. Network plots for IgG responses at the acute (b), C1 (d) and
C2 (f) stages were based on the adjacency matrix after adjusting for mean differences between
antisera (see Methods).
(TIF)
S5 Fig. Heatmaps and network representations of antisera similarity based on IgM
responses. Heatmap colours show degree of similarity between antisera (red, most similar;
blue, most distant) based on IgM responses at the acute (a), C1 (c) and C2 (e) stages. Colours
in side bars indicate clinical group, serological cluster, antigen cluster, genetic cluster, PoLV
group (legends in centre) and individual antisera. Asterisks mark antisera derived from the
same host as indicator antigens. Network plots for IgM responses at the acute (b), C1 (d) and
C2 (f) stages were based on the adjacency matrix after adjusting for mean differences between
antisera (see Methods).
(TIF)
S6 Fig. DBLα-tag antigen maps for IgG and IgM responses. Maps were constructed based
on IgG (a) and IgM (b) sero-reactivity data at the acute timepoint. Point size is proportional to
average sero-reactivity for the DBLα-tag antigen across all three time points. Point colours
indicate antigen cluster. Colours of outer circles indicate serological cluster. Asterisks mark
indicator antigens.
(TIF)
S7 Fig. Heatmaps and network representations of DBLα-tag antigen similarity based on
IgG responses. Heatmap colours show degree of similarity between DBLα-tag antigens (red,
most similar; blue, most distant) based on IgG responses at the acute (a), C1 (c) and C2 (e)
stages. Colours in side bars indicate clinical group, serological cluster, antigen cluster, genetic
cluster, PolV group (legends in centre) and individual antigens. Asterisks mark indicator anti-
gens. Network plots for IgG responses at the acute (b), C1 (d) and C2 (f) stages were based on
the adjacency matrix after adjusting for mean differences between antigens (see Methods).
(TIF)
S8 Fig. Heatmaps and network representations of DBLα-tag antigen similarity based on
IgM responses. Heatmap colours show degree of similarity between DBLα-tag antigens (red,
most similar; blue, most distant) based on IgM responses at the acute (a), C1 (c) and C2 (e)
stages. Colours in side bars indicate clinical group, serological cluster, antigen cluster, genetic
cluster, PolV group (legends in centre) and individual antigens. Asterisks mark indicator anti-
gens. Network plots for IgM responses at the acute (b), C1 (d) and C2 (f) stages were based on
the adjacency matrix after adjusting for mean differences between antigens (see Methods).
(TIF)
S9 Fig. Genetic window sub-maps with strongest correspondence to serological, antigen
and genetic clusters. Genetic maps based on genetic similarity among isolates in DBLα
regions for windows with midpoints at a, position 47; b, position 69; c, position 45; d, position
112. Sub-maps in a and b are those which correspond most (highest R2, values given in black
text with P-values) with serological clusters; sub-maps in c and d correspond best with antigen
and genetic clusters (Fig 6B), respectively. Colours of open symbols indicate serological, anti-
gen and genetic clusters (legends on right). In b, closed symbols indicate PoLV grouping. e,
Amino acid sequences in the region of the DBLα domain showing strongest correspondence
with serological and antigen clusters. Horizontal dashed lines indicate the windows used for
constructing the maps in a, b and c above. Membership of clusters and PoLV groups are indi-
cated in black text to the left of the figure. Black closed circles mark the antigens with the REY
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motif at the PoLV2 position (grey bar, Groups 2 and 5) which are highly concentrated in iso-
lates causing severe disease (Serological Cluster II). Asterisks mark indicator antigens. Col-
oured bars at the top of the figure indicate locations of homology blocks (see Fig 7 in main
text). The horizontal black line indicates the DBLα sub-domain defined as S2b by Rask et al.
(2010) with the arrowhead indicating that it extends beyond the window shown.
(TIF)
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